RFK Jr. To Be Grilled By Senators Funded By Big Pharma
Tristan Justice
President Donald Trump’s pick to run the Department of Health and Human Services (HHS) will be grilled in public hearings held by lawmakers who’ve pocketed more than $10 million from the pharmaceutical industry.
In a make-or-break moment for the movement to “make America healthy again,” Trump’s nominee to lead the crusade at HHS, environmental lawyer Robert F. Kennedy Jr., is scheduled to testify on Capitol Hill Wednesday and Thursday. Kennedy will appear before the Senate Finance Committee first, and the Health, Education Labor & Pensions Committee second.
“There are a series of industries that actually make money from keeping us sick,” Kennedy said in an interview with Dr. Phil last year, which the host re-shared this week. “You would think they want us healthy but they actually make more money if we get sicker. And of course, with the pharmaceutical companies, if you have a chronic illness then you’re a lifetime patient.”
Kennedy said the diabetes drug Ozempic in particular is being relied on to induce weight loss for a nation where more than two-thirds are overweight and 40 percent are obese. In November, the Biden administration proposed an 11th-hour rule to cover the medication under federal insurance programs. If confirmed as HHS secretary, Kennedy would decide whether to approve the $35 billion handout for drug manufacturers or terminate the proposal. Kennedy, however, has been a consistent critic of the medications now recommended by the American Academy of Pediatrics (AAP) for obese children as young as 12.
more
https://thefederalist.com/2025/01/28/senators-whove-raked-in-millions-from-big-pharma-to-question-rfk-jr-in-double-hearings/
